Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
ChiCGB vs BEAM in High-risk or R/R Lymphomas
- Status
- RECRUITING
- Phase
- PHASE3
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
- Status
- RECRUITING
- Phase
- PHASE2
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN)
- Status
- UNKNOWN
- Phase
- PHASE2
Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors
- Status
- TEMPORARILY_NOT_AVAILABLE
- Phase
- N/A
A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of ASP3082 in Adults With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
- Status
- COMPLETED
- Phase
- PHASE1
Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- NA
HAIC Combined With Toripalimab and Donafenib for Advanced BTC
- Status
- UNKNOWN
- Phase
- PHASE2
CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3